They said rapid weight loss was a well-established trigger of hair shedding and can also lead to iron or zinc deficiencies, which disrupt the hair growth cycle.
Absolute risk of alopecia was low, however
The study looked at 50,000 people on the drugs
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ…
People taking GLP-1 drugs have a low risk of hair loss, which is significantly higher than for those on other diabetes medications, a new study has found.
People on GLP-1 agonist drugs such as Mounjaro, Ozempic and Wegovy have been reporting hair loss
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type…
GLP-1 drugs such as Wegovy and Ozempic have been revolutionary for obesity and type 2 diabetes treatments, but questions remain about some of the side effects and potential…
Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged…
Secondo un nuovo studio, chi assume farmaci GLP-1 ha un rischio basso di perdita dei capelli, ma comunque superiore rispetto a chi prende altri antidiabetici.
New research suggests that hair loss can be a real, if tiny, risk of starting a GLP-1 drug like Ozempic.
Research into GLP-1 medications is not always robust but complaints such as digestive problems are well known